Captrust Financial Advisors Purchases New Shares in Sangamo Therapeutics, Inc. (NASDAQ:SGMO)
Captrust Financial Advisors acquired a new position in shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Free Report) in the fourth quarter, HoldingsChannel.com reports. The fund acquired 29,255 shares of the biopharmaceutical company’s stock, valued at approximately $30,000. Other large investors also recently bought and sold shares of the company. Golden State Equity Partners grew its […]
More Stories
Bobby Lee’s Net Worth And His Journey To Success
One of the oldest comedians from the US, Bobby Lee, has spent around 30 years in the field of comedy,...
UK Sanctions Russia After Inquiry Holds Putin Responsible for 2018 Novichock Poisonings
By Guy Birchall The UK issued new sanctions on Russia on Dec. 4, after a public inquiry into the death...
Indiana House Passes New Congressional Map Favoring Republicans
By Arjun Singh The Indiana House of Representatives on Dec. 5 passed a bill that would revise the state’s maps...
Economists Forecast Stronger US Growth, Lingering Inflation in 2026
By Tom Ozimek The U.S. economy will grow faster next year than previously projected and inflationary pressures will tick down,...
Noem Says US Travel Ban to Expand to Over 30 Countries
By Aldgra Fredly Homeland Security Secretary Kristi Noem said on Dec. 4 that the Trump administration is looking to increase...
Supreme Court Will Hear Trump’s Birthright Citizenship Case
By Matthew Vadum The U.S. Supreme Court decided on Dec. 5 to review whether President Donald Trump’s executive order ending birthright...